The Study of Ciprofol for the Suppression of Cardiovascular Responses to Tracheal Intubation

NCT06095570 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Intubation, Intratracheal
Adverse Effects

Interventions

DRUG: Ciprofol
DRUG: Remimazolam

Sponsor

The Second Affiliated Hospital of Hainan Medical University